Laparoscopic Subtotal Splenectomy: A Feasible Option in the Treatment of Splenic Metastasis
2024

Laparoscopic Subtotal Splenectomy for Splenic Metastasis

Sample size: 1 publication Evidence: moderate

Author Information

Author(s): Izquierdo Cristina MD, García-Picazo Alberto MD, Rodríguez Juan Pablo MD, Navarro Anna MD, Donisi Greta MD, Luque Eduardo MD, Ielpo Benedetto MD, PhD, FEBS, FACS, Burdío Fernando MD, PhD, FACS, Sánchez-Velázquez Patricia MD, PhD, FEBS

Primary Institution: University Hospital del Mar-IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain

Hypothesis

Can laparoscopic subtotal splenectomy (LSS) be a safe and feasible option for treating splenic metastasis?

Conclusion

LSS is a feasible and safe procedure when performed with appropriate laparoscopic equipment and by experienced surgeons.

Supporting Evidence

  • Laparoscopic subtotal splenectomy can help avoid complications associated with total splenectomy.
  • The patient had no complications and was discharged after 3 days.
  • Postoperative follow-up showed no evidence of complications.

Takeaway

This study shows that a special surgery called laparoscopic subtotal splenectomy can be done safely to help patients with certain types of spleen problems.

Methodology

The article provides a comprehensive overview of the laparoscopic subtotal splenectomy surgical technique, emphasizing key steps to avoid postoperative bleeding and complications.

Limitations

The study has a short follow-up period after surgery, which limits predictions about long-term survival or recurrence rates.

Participant Demographics

A 68-year-old man with a history of non-ischemic dilated cardiomyopathy and previous surgeries.

Digital Object Identifier (DOI)

10.1245/s10434-024-16549-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication